R&D Capitalization Event Signal

Article BigQuant

Summary

This study considers whether a company’s decision to capitalize research and development spending conveys information about future project profitability. Because accounting rules allow judgment in deciding whether development costs should be capitalized, the treatment may signal genuine expected benefits or reflect other reporting incentives. The report says companies with capitalized R&D underperformed their industries during the month after annual reports, suggesting investors may initially react negatively before they can judge whether the spending will generate future returns.

It proposes screening for firms more likely to be sending a credible signal using indicators of high R&D spending, weaker incentives to manage earnings, tighter cash flow constraints, and stricter external audit oversight. The selected shares reportedly continued to lag during the first month after reporting, followed by a valuation-recovery rise. The strategy is reported to have averaged 3.14% excess return over its industry and a 71% absolute-return win rate over four years. These are historical results; the supplied summary gives no details on sample construction, transaction costs, risk adjustment, or out-of-sample validation, and accounting choices can still be misleading.

Key ideas

Capitalizing R&D may signal expected future economic benefits, but accounting discretion can make the signal unreliable.
The study reports that firms capitalizing R&D lagged their industries during the month after annual reporting.
High R&D spending, low earnings-management incentives, cash flow constraints, and stronger external audits are proposed as credibility indicators.
The strategy seeks to capture a later valuation recovery after initial underperformance.
Reported historical returns do not establish that the effect will persist after costs or in other samples.

R&D Capitalization as an Equity Event and Value-Recovery Signal

Summary

Key ideas

Tags